Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy.

Heinen F, Desloovere K, Schroeder AS, Berweck S, Borggraefe I, van Campenhout A, Andersen GL, Aydin R, Becher JG, Bernert G, Caballero IM, Carr L, Valayer EC, Desiato MT, Fairhurst C, Filipetti P, Hassink RI, Hustedt U, Jozwiak M, Kocer SI, Kolanowski E, Krägeloh-Mann I, Kutlay S, Mäenpää H, Mall V, McArthur P, Morel E, Papavassiliou A, Pascual-Pascual I, Pedersen SA, Plasschaert FS, van der Ploeg I, Remy-Neris O, Renders A, Di Rosa G, Steinlin M, Tedroff K, Valls JV, Viehweger E, Molenaers G.

Eur J Paediatr Neurol. 2010 Jan;14(1):45-66. doi: 10.1016/j.ejpn.2009.09.005. Epub 2009 Nov 14. Review.

PMID:
19914110
2.

European consensus table 2006 on botulinum toxin for children with cerebral palsy.

Heinen F, Molenaers G, Fairhurst C, Carr LJ, Desloovere K, Chaleat Valayer E, Morel E, Papavassiliou AS, Tedroff K, Ignacio Pascual-Pascual S, Bernert G, Berweck S, Di Rosa G, Kolanowski E, Krägeloh-Mann I.

Eur J Paediatr Neurol. 2006 Sep-Nov;10(5-6):215-25. Epub 2006 Nov 13. Review.

PMID:
17097905
3.

The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy.

Criswell SR, Crowner BE, Racette BA.

Neurosurg Focus. 2006 Aug 15;21(2):e1. Review.

PMID:
16918222
4.

Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment.

Russman BS, Tilton A, Gormley ME Jr.

Muscle Nerve Suppl. 1997;6:S181-93. Review.

PMID:
9826990
5.

The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy.

Pidcock FS.

J Pediatr. 2004 Aug;145(2 Suppl):S33-5. Review.

PMID:
15292885
6.
7.

The use of botulinum toxin in pediatric disorders.

Gaebler-Spira D, Revivo G.

Phys Med Rehabil Clin N Am. 2003 Nov;14(4):703-25. Review.

PMID:
14580033
8.

[Botulinum toxin in the treatment of cerebral palsy].

Hayek S, Fatal-Valevski A.

Harefuah. 2000 Jan 16;138(2):144-7. Review. Hebrew. No abstract available.

PMID:
10883079
9.

Outcome measures used in studies of botulinum toxin in childhood cerebral palsy: a systematic review.

Baird MW, Vargus-Adams J.

J Child Neurol. 2010 Jun;25(6):721-7. doi: 10.1177/0883073809346846. Epub 2009 Oct 6. Review.

PMID:
19808988
10.

[Drug treatment for children with cerebral palsy].

Ben-Pazi H.

Harefuah. 2006 Jul;145(7):510-5, 550. Review. Hebrew.

PMID:
16900742
11.

Botulinum toxin use in neuro-rehabilitation to treat obstetrical plexus palsy and sialorrhea following neurological diseases: a review.

Intiso D, Basciani M.

NeuroRehabilitation. 2012;31(2):117-29. doi: 10.3233/NRE-2012-0781. Review.

PMID:
22951705
12.

Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.

Koman LA, Paterson Smith B, Balkrishnan R.

Paediatr Drugs. 2003;5(1):11-23. Review.

PMID:
12513103
13.

Botulinum toxin in children with cerebral palsy.

Singhi P, Ray M.

Indian J Pediatr. 2004 Dec;71(12):1087-91. Review.

PMID:
15630317
14.

[Spasticity and botulinum toxin in 2003. An update].

Fève A.

Neurochirurgie. 2003 May;49(2-3 Pt 2):265-70. Review. French.

PMID:
12746701
15.

[Treatment of spasticity with injections of botulinum toxin. Review of the literature].

Fève A, Decq P, Filipetti P, Kéravel Y.

Neurochirurgie. 1998 Sep;44(3):192-6. Review. French.

PMID:
9827435
16.
17.

Botulinum toxin as a new therapy option for voiding disorders: current state of the art.

Leippold T, Reitz A, Schurch B.

Eur Urol. 2003 Aug;44(2):165-74. Review.

PMID:
12875934
18.

[Treatment of spasticity in cerebral palsy with botulinum toxin].

Calderón-González R, Calderón-Sepúlveda RF.

Rev Neurol. 2002 Jan 1-15;34(1):52-9. Review. Spanish.

19.

Botulinum toxin in neuro-urological disorders.

Jost WH, Naumann M.

Mov Disord. 2004 Mar;19 Suppl 8:S142-5. Review.

PMID:
15027067
20.

Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy.

Wong V.

Pediatr Rehabil. 2003 Apr-Jun;6(2):85-96. Review.

PMID:
14534045

Supplemental Content

Support Center